Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cromoglycate
Drug ID BADD_D00537
Description A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.
Indications and Usage For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.
Marketing Status Prescription; OTC; Discontinued
ATC Code A07EB01; D11AH03; R01AC01; R03BC01; S01GX01
DrugBank ID DB01003
KEGG ID D07753
MeSH ID D004205
PubChem ID 2882
TTD Drug ID D0G7IY
NDC Product Code Not Available
Synonyms Cromolyn Sodium | Sodium Cromoglycate | Cromoglycate, Sodium | Disodium Cromoglycate | Cromoglycate, Disodium | Aarane | Bicromat Spray | Cromoglycate | Opticrom | FPL-670 | FPL 670 | FPL670 | Intal | Lomudal | Nalcrom | Nasalcrom | Vicrom | Cromolyn | Cromoglicic Acid | Acid, Cromoglicic | Cromoglycic Acid | Acid, Cromoglycic
Chemical Information
Molecular Formula C23H16O11
CAS Registry Number 16110-51-3
SMILES C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Eye pain06.08.03.002--
Fatigue08.01.01.002--
Feeling abnormal08.01.09.014--Not Available
Flatulence07.01.04.002--
Gastrointestinal pain07.01.05.005--
Glossitis07.14.01.001--Not Available
Haemoptysis02.01.02.006; 24.07.01.006; 22.02.03.004--Not Available
Hallucination19.10.02.002--
Headache17.14.01.001--
Hepatocellular injury09.01.07.008--Not Available
Hordeolum11.01.06.002; 06.04.04.006--Not Available
Hypersensitivity10.01.03.003--
Hypoaesthesia17.02.06.023--Not Available
Hypotension24.06.03.002--
Insomnia19.02.01.002; 17.15.03.002--
Irritability19.04.02.013; 08.01.03.011--
Joint swelling15.01.02.004--Not Available
Lacrimation increased06.08.02.004--
Laryngeal oedema10.01.05.003; 23.04.01.005; 22.04.02.001--
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.008--
Liver disorder09.01.08.001--Not Available
Lung infiltration22.01.02.004--Not Available
Malaise08.01.01.003--
Migraine24.03.05.003; 17.14.02.001--Not Available
Mood swings19.04.03.001--Not Available
Myalgia15.05.02.001--
Myopathy15.05.05.001--Not Available
Nasal congestion22.04.04.001--
Nausea07.01.07.001--
Nephrotic syndrome20.05.01.002--
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages